We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

AI-Powered Deep Learning Model Accurately Counts Cell Types in Whole Slide Images

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: A deep learning framework estimating cell types in a whole slide digital pathology image (Photo courtesy of University of Eastern Finland)
Image: A deep learning framework estimating cell types in a whole slide digital pathology image (Photo courtesy of University of Eastern Finland)

Improved methods for counting cell types in pathology images using deep learning approaches are much needed. Current techniques based on segmentation and regression face challenges such as the necessity for precise pixel-level annotations, difficulties in handling overlapping nuclei or obscured regions, and insufficient information on individual cell type locations. Moreover, probabilistic models tend to yield uncertain predictions and can lead to overconfident predictions. Researchers have now developed an advanced deep learning model to predict and count various cell types in the tumor microenvironment, which is expected to enhance the accuracy and efficiency of cancer diagnostics and treatment planning.

Identifying the different cell types in the tumor microenvironment can offer valuable insights into the tumor's histology and underlying biology. Precise and reliable cell type counting is also crucial for research and clinical applications. In addition, cell counts can be used to study the distribution of different cell types in the tumor microenvironment and its correlation with patient outcomes. In clinical settings, cell counts can help monitor therapy response and track disease progression. Researchers from the University of Eastern Finland (Kuopio, Finland) have proposed a new evidential multi-task deep learning approach, called CT-EMT, to overcome the limitations of current methods for cell type counting in whole slide tumor images. This approach formulates cell type density estimation and cell type counting as regression tasks, and nuclei segmentation as a pixel-level classification task.

The proposed cell type segmentation and counting approach has outperformed state-of-the-art HoVer-Net and StarDist models, with relative improvements of 21% and 12% in terms of mean panoptic quality. The developed model can deliver persuasive interpretations of diverse cell types and can be applied to various computational pathology tasks, such as tumor grading, prognosis, and treatment planning. This work will pave the way for the creation of more accurate and robust digital pathology tools that can support pathologists and clinicians in diagnosing and treating cancer patients.

“The UEF Cancer AI research team aims to explore the potential of using deep learning technology in cancer and health data analysis,” said senior researcher Hamid Behravan of the University of Eastern Finland. “Our study will involve the development and evaluation of cutting-edge deep learning algorithms for analyzing cancer and various types of health-related data, including medical images, genomic data, and electronic health records. We believe that this approach has the potential to significantly improve the accuracy and efficiency of breast cancer diagnosis and treatment planning, as well as to facilitate the discovery of new insights and patterns in cancer data. We hope that our research will contribute to the advancement of precision medicine and the development of more effective and personalized approaches to breast cancer prevention and prognosis.”

Related Links:
University of Eastern Finland

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Bordetella Test
Panther Fusion Bordetella Assay
Gold Supplier
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: The ClarityDX Prostate test can reduce unnecessary prostate biopsies by up to 35% (Photo courtesy of Nanostics)

Innovative Blood Test to Revolutionize Prostate Cancer Detection and Reduce Invasive Biopsies

One in six men will receive a prostate cancer diagnosis during their lives. Thankfully, if caught early, prostate cancer is highly treatable. However, the existing screening process has its limitations.... Read more


view channel
Image: The latest FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer (Photo courtesy of PixCell)

True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

An innovative 5-part differential Complete Blood Count (CBC) analyzer with direct capillary sampling capability significantly simplifies blood sampling and minimizes the pre-analytical process.... Read more


view channel
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell,... Read more


view channel
Image: On-chip pretreatment and rapid AST based directly on positive blood cultures (Photo courtesy of Liu Yang)

Integrated Solution for Rapid AST Directly From Positive Blood Cultures to Combat Bloodstream Infection

The presence of living bacteria in the bloodstream, known as bacteremia, can lead to serious conditions like bloodstream infections (BSIs) and sepsis, which can often be fatal. Quickly prescribing the... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more


view channel
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.